BACKGROUND: We systematically reviewed the evidence for an association between male circumcision and Human Papillomavirus (HPV) infection and genital warts in men. METHODS: PubMed and Embase were searched to 15 September 2010. The measure of effect was the adjusted odds ratio (OR) or rate ratio (RR) when present and the crude estimate otherwise. Random effects meta-analyses were used to calculate summary measures of effect. RESULTS: We identified 23 papers about the association between circumcision and HPV DNA. Circumcised men were less likely to have prevalent genital HPV infection than uncircumcised men (summary OR, 0.57, 95% confidence interval [CI], 0.45-0.71) with between-study heterogeneity (P-heterogeneity = 0.006; I(2) = 50.5%; 19 studies). Similar summary associations were seen in clinical and methodological subgroups. The effect of circumcision was stronger at the glans/corona (OR, 0.47; 95% CI, 0.37-0.60) and urethra (OR, 0.35; 95% CI, 0.12-1.05) compared with sites more distal to the foreskin. There was weak evidence that circumcision was associated with decreased HPV incidence (summary RR, 0.75, 95% CI, 0.57-0.99; 3 studies) and increased HPV clearance (summary RR, 1.33; 95% CI, 0.89-1.98; 3 studies) but no evidence of an association with prevalent genital warts (OR, 0.93, 95% CI, 0.65-1.33; 15 studies). CONCLUSIONS: Several countries are expanding access to voluntary medical male circumcision to reduce HIV prevalence. This could provide additional benefit in reducing HPV prevalence.
BACKGROUND: We systematically reviewed the evidence for an association between male circumcision and Human Papillomavirus (HPV) infection and genital warts in men. METHODS: PubMed and Embase were searched to 15 September 2010. The measure of effect was the adjusted odds ratio (OR) or rate ratio (RR) when present and the crude estimate otherwise. Random effects meta-analyses were used to calculate summary measures of effect. RESULTS: We identified 23 papers about the association between circumcision and HPV DNA. Circumcised men were less likely to have prevalent genital HPV infection than uncircumcised men (summary OR, 0.57, 95% confidence interval [CI], 0.45-0.71) with between-study heterogeneity (P-heterogeneity = 0.006; I(2) = 50.5%; 19 studies). Similar summary associations were seen in clinical and methodological subgroups. The effect of circumcision was stronger at the glans/corona (OR, 0.47; 95% CI, 0.37-0.60) and urethra (OR, 0.35; 95% CI, 0.12-1.05) compared with sites more distal to the foreskin. There was weak evidence that circumcision was associated with decreased HPV incidence (summary RR, 0.75, 95% CI, 0.57-0.99; 3 studies) and increased HPV clearance (summary RR, 1.33; 95% CI, 0.89-1.98; 3 studies) but no evidence of an association with prevalent genital warts (OR, 0.93, 95% CI, 0.65-1.33; 15 studies). CONCLUSIONS: Several countries are expanding access to voluntary medical male circumcision to reduce HIV prevalence. This could provide additional benefit in reducing HPV prevalence.
Authors: Virginia Senkomago; Danielle M Backes; Michael G Hudgens; Charles Poole; Kawango Agot; Stephen Moses; Peter J F Snijders; Chris J L M Meijer; Albertus T Hesselink; Nicolas F Schlecht; Robert C Bailey; Jennifer S Smith Journal: J Infect Dis Date: 2014-09-26 Impact factor: 5.226
Authors: Gerald Klinglmair; Renate Pichler; Bettina Zelger; Hasan Serkan Dogan; Tanja Becker; Johannes Esterbauer; Markus Riccabona; Wolfgang Loidl; Wolfgang Horninger; Josef Oswald Journal: World J Urol Date: 2012-12-14 Impact factor: 4.226
Authors: Brian J Morris; Robert C Bailey; Jeffrey D Klausner; Arleen Leibowitz; Richard G Wamai; Jake H Waskett; Joya Banerjee; Daniel T Halperin; Laurie Zoloth; Helen A Weiss; Catherine A Hankins Journal: AIDS Care Date: 2012-03-28
Authors: Jillian Pintye; Jared M Baeten; Lisa E Manhart; Connie Celum; Allan Ronald; Nelly Mugo; Andrew Mujugira; Craig Cohen; Edwin Were; Elizabeth Bukusi; James Kiarie; Renee Heffron Journal: Lancet Glob Health Date: 2014-10-22 Impact factor: 26.763
Authors: Sten H Vermund; José A Tique; Holly M Cassell; Megan E Pask; Philip J Ciampa; Carolyn M Audet Journal: J Acquir Immune Defic Syndr Date: 2013-06-01 Impact factor: 3.731